Section Arrow
Quote
TAK.NYSE
- Takeda Pharmaceutical Company Limited
Quotes are at least 15-min delayed:2026/08/19 08:29 EDT
Pre Market
Last
 18.07
+0.02 (+0.11%)
Bid
18.09
Ask
18.2
High 18.16 
Low 17.95 
Volume 3.35K 
Regular Hours (Closed)
Last
 18.05
+0.67 (+3.86%)
Day High 
18.16 
Prev. Close
17.38 
1-M High
17.83 
Volume 
3.81M 
Bid
18.09
Ask
18.2
Day Low
17.8341 
Open
17.86 
1-M Low
16.3 
Market Cap 
55.50B 
Currency 美元 
P/E -- 
%Yield 3.49 
10-SMA 17.26 
20-SMA 17.23 
50-SMA 16.58 
52-W High 18.895 
52-W Low 12.99 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-52.25/237.57
Enterprise Value
4,425.18B
Balance Sheet
Book Value Per Share
14.85
Cash Flow
Cash Flow Yield
0.12
Income Statement
Total Revenue
4,505.72B
Operating Revenue Per Share
8.71
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AMLXAmylyx Pharmaceuticals35.11+13.68+63.84%-- 
Pre Market 36.61 +1.5 +4.27%
SXTCChina Sxt Pharmaceuticals Inc5.13+1.38+36.80%-- 
Pre Market 4.95 -0.18 -3.51%
HLNHaleon plc9.72+0.14+1.46%19.54PE
Pre Market 9.7588 +0.0388 +0.40%
VTRSViatris16.17-0.06-0.37%-- 
Pre Market 16.4527 +0.2827 +1.75%
HIMSHims & Hers Health27.39-1.22-4.26%-- 
Pre Market 27.19 -0.2 -0.73%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.